Correspondence in relation to critical appraisal by Chapman et al

Thorax

Volumn 66, Issue 1, 2011, Pages 86-

  Peters, Matthew J ^a   Jenkins, Christine R ^a  

^a ANZAC Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ASTHMA; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; HOSPITALIZATION; HUMAN; LETTER; MAINTENANCE THERAPY; MONOTHERAPY; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SINGLE MAINTENANCE AND RELIEVER THERAPY; SYMPTOM;

EID: 78650209007     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.149633     Document Type: Letter

References (6)

1. Chapman KR, Barnes NC, Greening AP, et al. Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal. Thorax 2010;65:747-52.
2. Bateman ED, Reddel HK, Eriksson G, et al. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol 2010;125:600-8.
3. Chapman KR. SMART isn't. J Allergy Clin Immunol 2010;125:609-10.
4. Cates CJ, Lasserson TJ. Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev 2009;(2):CD007313.
5. Cates CJ, Lasserson TJ. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children (Review). Cochrane Database Syst Rev 2009;(2): CD007085.
6. Pavord ID, Jeffery PK, Qiu Y, et al. Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide/formoterol. J Allergy Clin Immunol 2009;123:1083-9.